Cleared Traditional

K162929 - Stryker Navigation System with CranialM...

K162929 is an FDA 510(k) clearance for Stryker Navigation System with CranialM..., manufactured by Stryker Corporation. The device is a Class 2 Neurology device with product code HAW cleared through the Traditional 510(k) pathway after a 126-day FDA review.

K162929 · Stryker Corporation · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 2017
Decision
126d
Days
Class 2
Risk

K162929 is an FDA 510(k) clearance for the Stryker Navigation System with CranialMap software application, Stryker Crani.... Classified as Neurological Stereotaxic Instrument (product code HAW), Class II - Special Controls.

Submitted by Stryker Corporation (Freiburg Baden-Wurttemberg, DE). The FDA issued a Cleared decision on February 22, 2017 after a review of 126 days - within the typical 510(k) review window.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4560 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

View all Stryker Corporation devices

FDA 510(k) Submission Details - K162929

510(k) Number K162929 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 19, 2016
Decision Date February 22, 2017
Days to Decision 126 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
22d faster than avg
Panel avg: 148d · This submission: 126d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HAW Device Classification - Class 2, Special Controls

Product Code HAW Neurological Stereotaxic Instrument
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4560
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - HAW Neurological Stereotaxic Instrument

All 262
Devices cleared under the same product code (HAW) and FDA review panel - the closest regulatory comparables to K162929.
Leksell Vantage Stereotactic System
K171123 · Elekta Instrument AB · Sep 2017
StealthConnect Remote Viewing, Planning and Collaboration System
K162655 · Medtronic Navigation, Inc. · Apr 2017
StealthStation S8 System Platforms and StealthStation Cranial Software
K162309 · Medtronic Navigation, Inc. · Mar 2017
Cranial Reducing Tubes
K162604 · Medtronic Navigation, Inc. · Dec 2016
CRW STEREOTACTIC SYSTEM
K160811 · Integra LifeSciences Corporation · Dec 2016
StealthStation System with Cranial Software
K153660 · Medtronic Navigation, Inc. · Sep 2016